Bischoff Caleb J, Prenger Brent A, Rucinski Kylee, DeFroda Steven F
Department of Orthopaedic Surgery, University of Missouri, Columbia, MO, USA.
Eur J Orthop Surg Traumatol. 2025 Jul 25;35(1):321. doi: 10.1007/s00590-025-04442-x.
Osteonecrosis of the femoral head (ONFH) is a debilitating condition caused by disrupted blood supply, leading to bone tissue death, pain, and reduced mobility. The purpose of this review is to consolidate current knowledge of ONFH, focusing on treatment options and highlighting the potential of innovative therapies to optimize management and delay disease progression.
The authors performed a review of the current literature examining the clinical presentation, diagnostic imaging techniques, and both non-surgical and surgical treatment approaches for ONFH. The literature was summarized in a narrative review using sources from PubMed, SCOPUS, and Google Scholar, with a focus on studies providing current and emerging evidence relevant to clinical decision-making and therapeutic innovation.
ONFH diagnosis relies on a combination of clinical evaluation and imaging modalities such as radiographs (XRs) and magnetic resonance imaging. Early-stage ONFH can be managed with non-surgical options like biophysical stimulation and pharmacologic therapies to preserve joint function. Advanced cases often require surgical interventions, including core decompression, osteotomies, and autologous bone grafting, which restore the joint surface and delay progression to total hip arthroplasty. Emerging treatments, such as bone marrow aspirate concentrate, platelet-rich plasma, and osteochondral allograft, have shown promise in enhancing surgical outcomes and improving bone regeneration.
ONFH management requires a multidisciplinary approach tailored to disease stage and patient-specific factors. While early interventions focus on preserving joint integrity, advanced stages benefit from surgical techniques and innovative therapies. This review aims to improve the understanding of ONFH and facilitate accurate diagnosis and appropriate management, ultimately improving patient outcomes.
股骨头坏死(ONFH)是一种因血液供应中断导致的使人衰弱的病症,会引发骨组织坏死、疼痛和活动能力下降。本综述的目的是整合目前关于股骨头坏死的知识,重点关注治疗方案,并突出创新疗法在优化管理和延缓疾病进展方面的潜力。
作者对当前文献进行了综述,研究股骨头坏死的临床表现、诊断成像技术以及非手术和手术治疗方法。使用来自PubMed、SCOPUS和谷歌学术的资料,以叙述性综述的形式对文献进行了总结,重点关注提供与临床决策和治疗创新相关的当前及新出现证据的研究。
股骨头坏死的诊断依赖于临床评估和诸如X线片(XRs)及磁共振成像等成像方式的结合。早期股骨头坏死可通过生物物理刺激和药物治疗等非手术选择进行管理,以保留关节功能。晚期病例通常需要手术干预,包括髓芯减压、截骨术和自体骨移植,这些手术可恢复关节表面并延缓进展至全髋关节置换术。诸如骨髓抽吸浓缩物、富血小板血浆和骨软骨异体移植等新出现的治疗方法,在提高手术效果和促进骨再生方面已显示出前景。
股骨头坏死的管理需要根据疾病阶段和患者特定因素采取多学科方法。早期干预侧重于保留关节完整性,而晚期则受益于手术技术和创新疗法。本综述旨在增进对股骨头坏死的理解,促进准确诊断和适当管理,最终改善患者预后。